Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics

被引:4
作者
Nelson, J. Craig [1 ]
机构
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
关键词
TREATMENT-RESISTANT DEPRESSION; OPEN-LABEL; DOUBLE-BLIND; ANTIDEPRESSANT THERAPY; OLANZAPINE/FLUOXETINE COMBINATION; ARIPIPRAZOLE AUGMENTATION; DISORDER; EFFICACY; SAFETY; FLUOXETINE;
D O I
10.1176/appi.ajp.2015.15091220
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
[No abstract available]
引用
收藏
页码:1176 / 1178
页数:3
相关论文
共 50 条
[21]   Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients [J].
Yasui-Furukori, Norio ;
Kaneda, Ayako ;
Sugawara, Norio ;
Tomita, Tetsu ;
Kaneko, Sunao .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (06) :806-812
[22]   Adjunctive Use of Atypical Antipsychotics for Treatment-Resistant Generalized Anxiety Disorder [J].
Lorenz, Raymond A. ;
Jackson, Cherry W. ;
Saitz, Marianne .
PHARMACOTHERAPY, 2010, 30 (09) :942-951
[23]   Adjunctive Brexpiprazole: A Review in Major Depressive Disorder [J].
McKeage, Kate .
CNS DRUGS, 2016, 30 (02) :91-99
[24]   Medical Costs and Hospitalizations Among Patients with Depression Treated with Adjunctive Atypical Antipsychotic Therapy: An Analysis of Health Insurance Claims Data [J].
Halpern, Rachel ;
Nadkarni, Anagha ;
Kalsekar, Iftekhar ;
Nguyen, Hiep ;
Song, Rui ;
Baker, Ross A. ;
Nelson, J. Craig .
ANNALS OF PHARMACOTHERAPY, 2013, 47 (7-8) :933-945
[25]   Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study [J].
Cuomo, Alessandro ;
Carmellini, Pietro ;
Garo, Maria Luisa ;
Barilla, Giovanni ;
Libri, Claudia ;
Spiti, Alessandro ;
Goracci, Arianna ;
Bolognesi, Simone ;
Fagiolini, Andrea .
JOURNAL OF AFFECTIVE DISORDERS, 2023, 321 :102-107
[26]   Adjunctive Aripiprazole for Depression: Predictive Value of Early Assessment [J].
Muzina, David J. ;
Chambers, Jessie S. ;
Camacho, Trixia A. ;
Eudicone, James M. ;
Forbes, Robert A. ;
Berman, Robert M. ;
Baker, Ross A. .
AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (12) :793-801
[27]   Efficacy and Safety of Adjunctive Serotonin-Dopamine Activity Modulators in Major Depression: A Meta-Analysis of Randomized Controlled Trials [J].
Mishra, Archana ;
Sarangi, Sudhir Chandra ;
Maiti, Rituparna ;
Sood, Mamta ;
Reeta, K. H. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (06) :721-732
[28]   New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression [J].
Orzelska-Gorka, Jolanta ;
Mikulska, Joanna ;
Wiszniewska, Anna ;
Biala, Grazyna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[29]   Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options [J].
Hassan, Amany K. ;
Farmer, Kevin C. ;
Brahm, Nancy C. ;
Keast, Shellie ;
Nesser, Nancy ;
Neas, Barbara R. .
JOURNAL OF MENTAL HEALTH, 2016, 25 (06) :486-491
[30]   Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes [J].
Spielmans, Glen I. ;
Berman, Margit I. ;
Linardatos, Eftihia ;
Rosenlicht, Nicholas Z. ;
Perry, Angela ;
Tsai, Alexander C. .
PLOS MEDICINE, 2013, 10 (03)